Effective April 1, 2020, IMCD N.V., headquartered in Rotterdam (The Netherlands), will be marketing and distributing Röhm’s entire portfolio of acrylic-based CYROLITE® copolymers and CYROLITE® MD products for the medical device and diagnostics markets in Europe except Switzerland and Liechtenstein.
Röhm is a technology leader for polymethyl methacrylate (PMMA) molding compounds. Its CYROLITE® products are designed to meet the stringent requirements of the medical and diagnostic devices and have proven successful in a wide range of applications for over 40 years.
For this new collaboration, Röhm is teaming up with IMCD, a market-leader in the sales, marketing and distribution of speciality chemicals and food ingredients. IMCD provides a dedicated team of technical and commercial experts who work in close relationship with customers across EMEA, while Röhm brings in the reliable manufacturing operations, quality products, and innovative solutions of its medical acrylics portfolio.
CYROLITE® products are transparent, impact-modified thermoplastic molding compounds specially developed for medical technology. These products are the perfect solution for applications requiring superior balance of properties as they are tough, highly transparent, bondable, sterilizable (gamma, e-beam, EtO), easy to process and chemical resistant. All CYROLITE® product grades are BPA free and biocompatible in compliance with USP Class VI and ISO 10993-1. The main applications for these products are in disposable medical device and diagnostics components, such as, infusion and catheter accessories, as well as blood/plasma separators, chest drainage, filters and diagnostics cassettes.
“Our customers will benefit from IMCD’s great service and extended supply chain network. IMCD is a leading distributor that we can count on with excellent knowledge of the market and sales expertise,” says Sergio Corbella, Director Medical Europe within the Business Unit Molding Compounds of Röhm.
Siobhan Bastiansen, Market Manager Medical at IMCD Advanced Materials Group added “We, in the IMCD Medical Polymers Team are delighted to welcome Röhm on board as our new partner. The CYROLITE® products are an excellent fit with our current product portfolio which is offered across Europe. We look forward to promoting these specialty materials to our extensive medical and diagnostic customer base as well as providing a comprehensive service to existing CYROLITE® customers.”
